Clinical outcome of patients with Helicobacter pylori infection: The bug, the host, or the environment?

Postgraduate Medical Journal

Volumn 82, Issue 967, 2006, Pages 338-342

  Sgouros, S N ^a,b   Bergele, C ^c  

^a Athens Naval and Veterans Hospital ^*  (Greece)

^b ATHENS NAVAL HOSPITAL   (Greece)

^c EVANGELISMOS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; CAGA PROTEIN; HEAT SHOCK PROTEIN 60; INTERLEUKIN 8; METAL; UREASE; VACUOLATING TOXIN;

BACTERIAL COLONIZATION; BACTERIAL FLAGELLUM; BACTERIAL GENE; BACTERIAL VIRULENCE; CELL MOTILITY; DISEASE COURSE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOST RESISTANCE; HUMAN; ICEA GENE; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PATHOGENICITY ISLAND; PEPTIC ULCER; REVIEW; SPECIES INVASION; STOMACH ULCER; TISSUE INJURY;

ENVIRONMENT; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; STOMACH NEOPLASMS;

EID: 33646873252     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2005.038273     Document Type: Review

References (51)

1. Cover TL, Blaser MJ. Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention. Adv Int Med 1996;41:85-117.
2. Tomb JF, White O, Kerlavage AR, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997;388:539-47.
3. Alm RA, Ling LS, Moir DT, et al. Genomic sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 1999;397:176-80.
4. Ottemann MK, Lowenthal AK. Helicobacter pylori uses motility for initial colonization and to attain robust infection. Infect Immun 2002;70:1984-90.
5. Andrutis KA, Fox JG, Schauer DB, et al. Inability of an isogenic urease negative mutant strain of Helicobacter mustelae to colonize me ferret stomach. Infect Immun 1995;63:3722-5.
6. Athmann C, Zeng N, Kang T, et al. Local pH elevation mediated by the intrabacterial urease of Helicobacter pylori cocultured with gastric cells. J Clin Invest 2000;106:339-47.
7. Rektorschek M, Weeks D, Sachs G, et al. Influence of pH on metabolism and urease activity of Helicobacter pylori. Gastroenterology 1998;115:628-41.
8. Scott DR, Marcus EA, Weeks DL, et al. Expression of the Hp urel gene is required for acidic pH activation of cytoplasmic urease. Infect Immun 2000;68:470-7
9. Segal ED, Falkow S, Tomkins LS. Helicobacter pylori attachment to gastric cells induces cytoskeletal rearrangements and tyrosine phosphorylahon of host cell proteins. Proc Natl Acad Sci U S A 1996;93:1259-64.
10. Mc Gee DJ, Mobley HL. Mechanisms of Helicobacter pylori infection; bacterial factors. Curr Top Microbiol Immunol 1999;241:155-80.
11. Keates S, Hitti YS, Upton M, et al. Helicobacter pylori infection activates NF-kappaB in gastric epithelial cells. Gastroenterology 1997;113:1099-109.
12. Gerhard M, Lehn N, Neumayer N, et al. clinical relevance of the Helicobacter pylori gene for blood group antigen-binding adhesin. Proc Natl Acad Sci U S A 1999;96:12778-83
13. Odenbreit S, Till M, Hofreuter D, et al. Genetic and functional characterization of the alpAB gene locus essential for the adhesion of Helicobacter pylori to human gastric tissue. Mol Microbiol 1999;31:1537-48.
14. Mandavi J, Sonden B, Hurtig, et al. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 2002;297:573-8.
15. Ng EKW, Thompson SA, Pérez-Pérez GI, et al. Helicobacter pylori heat shock protein A: serologic responses and genetic diversity. Clin Diagn Lab Immun 1999;6:377-82.
16. Kawahara Y, Yokota K, Mizuno M, et al. Antibodies to human gastric epithelial cells and heat shock protein 60 in Helicobacter pylori positive mucosa associated lymphoid tissue lymphoma. Gut 1999;45:20-3.
17. Yamaguchi H, Osaki T, Kai M, et al. Immunoglobulin G1 antibody response to Helicobacter pylori heat shock protein 60 is closely associated with low-grade gastric mucosa-associated lymphoid tissue lymphoma. Clin Diagn Lab Immun 2001;8:1056-9.
18. Escolar L, Perez-Martin J, de Lorenzo V. Opening the iron-box: transcriptional metalloregulation by the Fur protein. J Bacteriol 1999;181:6223-9.
19. Waidner B, Greiner S, Odenbreit S, et al. Essential role of ferritin Pfr in Helicobacter pylori iron metabolism and gastric colonization. Infect Immun 2002;70:3923-9.
20. Harford WV, Barnett C, Lee E, et al. Acute gastritis with hypochlorhydria: report of 35 cases with long term follow up. Gut 2000;47:467-72.
21. +-ATPase. Gut 2001;48:157-62.
22. Olczak AA, Olson JW, Maier RJ. Oxidative-stress resistance mutants of Helicobacter pylori. J Bacteriol 2002;184:3186-93.
23. Yamaoka Y, Kita M, Kodama T, et al. Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut 1998;42:609-17.
24. Covacci A, Telford JL, DelGiudice G, et al. Helicobacter pylori virulence and genetic geography. Science 1999;284:1328-33.
25. de Figueiredo Soares T, de Magalhaes Queiroz DM, Mendes EN, et al. The interrelationship between Helicobacter pylori vacuolating cytotoxin and gastric carcinoma. Am J Gastroenterol 1998;93:1841-7.
26. Miehlke S, Meining A, Morgner A, et al. Frequency of vacA genotypes and cytotoxin activity in Helicobacter pylori associated with low-grade gastric mucosa associated lymphoid tissue lymphoma. J Clin Microbiol 1998;36:2369-70.
27. Pagliaccia C, de Bernard M, Lupetti P, et al. The m2 form of the Helicobacter pylori cytotoxin has cell type specific vacuolating activity. Proc Natl Acad Sci U S A 1998;95:10212-17.
28. Yamaoka Y, Kodama T, Kita M, et al. Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter 1998;4:241-53.
29. de Bernard M, Burroni D, Papini E, et al. Identification of the Helicobacter pylori vacA toxin domain active in the cell cytosol. Infect Immun 1998;66:6014-16.
30. Papini E, Satin B, Norais N, et al. Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin. J Clin Invest 1998;102:813-20.
31. Sutton P, Wilson J, Genta R, et al. A genetic basis for atrophy: dominant non-responsiveness and Helicobacter induced gastritis in F1 hybrid mice. Gut 1999;45:335-40.
32. Dundon WG, Nishioka H, Polenghi A, et al. The neutrophil-activating protein of Helicobacter pylori. Int J Med Microbiol 2002;291:545-50.
33. Censini S, Lange C, Xiang Z, et al. CagA pathogenicity island of Helicobacter pylori encodes type-I specific and disease associated virulence factors. Proc Natl Acad Sci U S A 1996;93:14648-53.
34. Naumann M, Wessler S, Bartsch C, et al. Activation of activator protein 1 and stress response kinases in epithelial cells colonized by Helicobacter pylori encoding the cag pathogenicity island. J Biol Chem 1999;274:31655-62.
35. Yamaoka Y, Kodama T, Gutierrez O, et al. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 1999;37:2274-9.
36. van Doorn LJ, Figueiredo C, Sanna R, et al. Clinical relevance of cagA, vacA and iceA status of Helicobacter pylori. Gastroenterology 1998;115:58-66.
37. Nishiya D, Shimoyama T, Fukuda S, et al. Evaluation of the clinical relevance of the iceA1 gene in patients with Helicobacter pylori infection in Japan. Scand J Gastroenterol 2000;35:36-9.
38. Nedrud JG, Czinn SJ. Host, heredity and helicobacter. Gut 1999;45:323-4.
39. Graham, Yamaoka Y. Disease specific Helicobacter pylori virulence factors; the unfulfilled promise. Aliment Pharm Ther 2000;5(suppl 1):S3-9.
40. Malaty HM, Evans DG, Evans DJ, et al. Helicobacter pylori in Hispanics: comparison with blacks and whites of similar age and socioeconomic class. Gastroenterology 1992;103:813-16.
41. Kang JY, Yeoh KJ, Ho KY, et al. Racial differences in Helicobacter pylori seroprevalence in Singapore: correlation with differences in peptic ulcer frequency. J Gastroenterol Hepatol 1997;12:655-9.
42. Malaty HM, Engstrand L, Pedersen NL, et al. Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann Intern Med 1994;120:982-6.
43. Forman G. Is there significant variation in the risk of gastric cancer associated with Helicobacter pylori infection? Aliment Pharm Ther 1998;12(suppl 1):3-7.
44. McColl KEL, El-Omar E. Helicobacter pylori and disturbance of gastric function associated with duodenal ulcer disease and gastric cancer. Scand J Gastroenterol 1996;31(suppl 215):32-7.
45. Fox JG, Wang TC. Helicobacter pylori- not a good bug after all. N Engl J Med 2001;345:829-32.
46. Wang TC, Dangler CA, Chen D, et al. Synergistic interaction between hypergastrinaemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000;118:36-47.
47. El-Omar EM, Carrington M, Chow WII, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
48. Graham DY, Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 1997;113:1983-91.
49. Joosens JV, Hill MJ, Elliott P, et al. Dietary salt, nitrate and stomach cancer mortality in 24 countries. Int J Epidemiol 1996;25:494-504.
50. Huwez FU, Thirlwell D, Cockayne A, et al. Mastic gum kills Helicobacter pylori. N Engl J Med 1998;339:1946.
51. Yee YK, Koo MW, Szeto ML. Chinese tea consumption and lower risk of Helicobacter infection. J Gastroenterol Hepatol 2002;17:552-5.